Innovest Global ($IVST) Q1 Financials Beat Revenue

New Post Public Reply Private Reply Replies (0) Message Board
SpotlightGrowth1
378
Innovest Global ($IVST) Q1 Financials Beat Revenue Estimates, $600K+ Cash On Hand, and Cancelled 50 Million Shares


CLEVELAND, Ohio, April 16, 2018 (GLOBE NEWSWIRE) — Innovest Global Inc. (OTC PINK: IVST) reports $708K in first quarter revenue, current assets of $932,000 and that the company has cancelled 50 million shares from the market in the process of completing its mining exit. Financials posted simultaneous to this news release.

Since the mid-quarter February Shareholder update noting higher than expected sales, the trend continued throughout the quarter ending ahead of targets at $708K. This is due to successfully integrated acquisitions in the Commercial & Industrial Division during the first quarter. Total current assets of $932,000 compared to current liabilities of $352,000 show the company has a “quick ratio”, or short-term acid test of financial strength of 2.6, four times stronger than the Conglomerates industry average ratio of 0.6.

The company worked with its auditors to appropriately book the exit from mining, and in the process retired 50 million common shares belonging to past insiders. This information is discussed in the reported financials.

The Board of Directors is now majority independent. Dan Martin, the CEO and largest shareholder, remains the board Chairman. John Klopp (CEO of Klopp Investment Management, a second generation blue-chip platform money manager) and Jason Painley, CPA (CFO of Mechanics Bank, and a former Federal Reserve Bank expert on holding companies and compliance) are the two independent members. Innovest previously released news on each.

The acquisition pipeline remains full. “The response we are getting from business and technology owners that want to get to the next level is very encouraging,” said Innovest CEO, Dan Martin. “We are incrementally increasing the size of the organizations we are looking to acquire, and seeing great progress.”

Innovest Global, Inc. (OTC Pink: IVST) is in the Conglomerates Industry, currently operating a Commercial & Industrial Division under the leadership of Division President Damon Mintz, and soon launching a Biotechnology & Health Sciences Division by Division President Dr. Dwain Morris-Irvin, Ph.D., M.P.H. Revenue growth strategy continues to focus on organic sales, and acquisitions of existing companies that are strategically appropriate. Management is very enthusiastic about the start of 2018 and the continued demand for its products, services, and partnership opportunities.

Follow us on Twitter @innovestglobal for important company updates! For more information on IVST contact info@innovestglobal.com, or call Innovest investor Relations Matt Rego at 216.815.1122.

http://www.innovestglobal.com

Safe Harbor Statement: This news release contains “forward-looking statements”, which are statements that are not purely historical and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Disclaimer:

Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.

All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated two thousand five hundred dollars cash and fifty thousand restricted shares for the creation and dissemination of this content.

This material does not represent an investment solicitation. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.

The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.

Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: http://spotlightgrowth.com/index.php/disclosures/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 271

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 338

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 126

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 382

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 445

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 246

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 314

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 250

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 155

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

Century Communities Celebrates New Home Community Launch

Updated Category News Views 171

Exciting Grand Opening for Willow Glenn Community Century Communities, Inc. (NYSE: CCS), a prominent national homebuilder, is thrilled to announce the upcoming Grand Opening for Willow Glenn, a remarkable new residential community featuring spacious, modern two-story homes. Situated with breathtaking views of Mt. Rainier, this community is designed to elevate the living...

Continue Reading
Universal Health Services Welcomes Darren Lehrich as New VP

Updated Category News Views 161

Universal Health Services Announces New Addition to Leadership Universal Health Services, Inc. (NYSE: UHS), a key player in the healthcare sector, has recently welcomed Darren Lehrich to its leadership team as Vice President of Investor Relations. In his new capacity, Lehrich will report directly to CFO Steve Filton, aiming to enhance investor engagement in this critical...

Continue Reading
Provident Financial Services Achieves Impressive Q3 Earnings Results

Updated Category News Views 62

Recent Earnings Update Provident Financial Services, Inc. (NYSE: PFS) has recently shared its financial results for its third quarter, showcasing a remarkable net earnings figure of $46.4 million, equivalent to $0.36 per share. These encouraging results were shared by CEO Tony Labozzetta during a call with investors. He highlighted the successful integration of the...

Continue Reading
EnviroGold Global Strengthens Board with New Executive Appointment

Updated Category News Views 71

EnviroGold Global Welcomes Jackie Przybylowski to Board EnviroGold Global Limited (CSE: NVRO | OTCQB: ESGLF | FSE: YGK) is thrilled to announce that Jackie Przybylowski, a distinguished executive in the mining and capital markets sector, has joined its Board of Directors. This pivotal appointment takes effect as the company progresses the rollout of its innovative NVRO...

Continue Reading
Syensqo Reports Strong Q4 and Full Year 2024 Performance

Updated Category News Views 754

Syensqo's Remarkable Fourth Quarter and Full Year 2024 Performance Syensqo recently announced its highlights for the fourth quarter and full year of 2024, showcasing impressive growth in a challenging market landscape. This performance reflects the company's resilience and strategic vision. Quarter Four Achievements During Q4 of 2024, Syensqo achieved net sales of €1.6...

Continue Reading